XML 66 R40.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation (Tables)
12 Months Ended
May 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Non-qualified Stock Options Granted

The table below sets forth the non-qualified stock options granted during each of the last three fiscal years ended May 31. For each grant, the exercise price was equal to the closing market price of the underlying common shares at the respective grant date. The fair values of these stock options were based on the Black-Scholes option pricing model, calculated at the respective grant dates. The calculated pre-tax stock-based compensation expense for these stock options will be recognized on a straight-line basis over the three-year vesting period of the stock options.

 

(in thousands, except per share amounts)

 

2022

 

 

2021

 

 

2020

 

Granted

 

 

55

 

 

 

116

 

 

 

101

 

Weighted average exercise price, per share

 

$

60.19

 

 

$

36.93

 

 

$

38.91

 

Weighted average grant date fair value, per share

 

$

19.76

 

 

$

10.43

 

 

$

10.21

 

Pre-tax stock-based compensation

 

$

1,077

 

 

$

1,213

 

 

$

1,029

 

Schedule of Assumptions Used to Determine Fair Value of Stock Options

The weighted average fair value of stock options granted in fiscal 2022, fiscal 2021 and fiscal 2020 was based on the following weighted average assumptions:

 

 

 

2022

 

 

2021

 

 

2020

 

Dividend yield

 

 

2.10

%

 

 

2.94

%

 

 

2.42

%

Expected volatility

 

 

41.62

%

 

 

40.82

%

 

 

33.10

%

Risk-free interest rate

 

 

1.10

%

 

 

0.43

%

 

 

1.86

%

Expected life (years)

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

 

Summary of Stock Option Activity

The following tables summarize our stock option activity for the fiscal years ended May 31:

 

 

 

2022

 

 

2021

 

 

2020

 

(in thousands, except per share amounts)

 

Stock
Options

 

 

Weighted
Average
Exercise
Price

 

 

Stock
Options

 

 

Weighted
Average
Exercise
Price

 

 

Stock
Options

 

 

Weighted
Average
Exercise
Price

 

Outstanding, beginning of year

 

 

602

 

 

$

36.44

 

 

 

1,352

 

 

$

27.34

 

 

 

1,555

 

 

$

24.01

 

Granted

 

 

55

 

 

 

60.19

 

 

 

116

 

 

 

36.93

 

 

 

101

 

 

 

38.91

 

Exercised

 

 

(53

)

 

 

23.80

 

 

 

(854

)

 

 

22.16

 

 

 

(303

)

 

 

13.99

 

Forfeited

 

 

(2

)

 

 

44.69

 

 

 

(12

)

 

 

31.52

 

 

 

(1

)

 

 

43.04

 

Outstanding, end of year

 

 

602

 

 

$

39.66

 

 

 

602

 

 

$

36.44

 

 

 

1,352

 

 

$

27.34

 

Exercisable at end of year

 

 

447

 

 

$

37.68

 

 

 

389

 

 

$

35.55

 

 

 

1,167

 

 

$

25.34

 

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

Number of

 

 

Remaining

 

 

Aggregate

 

 

 

Stock

 

 

Contractual

 

 

Intrinsic

 

 

 

Options

 

 

Life

 

 

Value

 

 

 

(in thousands)

 

 

(in years)

 

 

(in thousands)

 

May 31, 2022

 

 

 

 

 

 

 

 

 

Outstanding

 

 

602

 

 

 

5.15

 

 

$

4,987

 

Exercisable

 

 

447

 

 

 

4.09

 

 

$

4,065

 

 

 

 

 

 

 

 

 

 

 

May 31, 2021

 

 

 

 

 

 

 

 

 

Outstanding

 

 

602

 

 

 

5.61

 

 

$

18,037

 

Exercisable

 

 

389

 

 

 

4.15

 

 

$

12,415

 

 

 

 

 

 

 

 

 

 

 

May 31, 2020

 

 

 

 

 

 

 

 

 

Outstanding

 

 

1,352

 

 

 

3.21

 

 

$

8,846

 

Exercisable

 

 

1,167

 

 

 

2.44

 

 

$

8,846

 

Summary of Non-Vested Stock Option Awards

The following table summarizes information about non-vested stock option awards for the fiscal year ended May 31, 2022:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

 

 

Stock Options

 

 

Fair Value

 

 

 

(in thousands)

 

 

Per Share

 

Non-vested, beginning of year

 

 

213

 

 

$

10.29

 

Granted

 

 

55

 

 

 

19.76

 

Vested

 

 

(111

)

 

 

11.50

 

Forfeited

 

 

(2

)

 

 

13.36

 

Non-vested, end of year

 

 

155

 

 

$

13.66

 

Schedule of Service-Based Restricted Common Shares Granted

The table below sets forth the service-based restricted common shares granted under the Plans during each of fiscal 2022, fiscal 2021 and fiscal 2020. The calculated pre-tax stock-based compensation expense for these restricted common shares will be recognized on a straight-line basis over their respective three-year service periods.

 

(in thousands, except per share amounts)

 

2022

 

 

2021

 

 

2020

 

Granted

 

 

192

 

 

 

307

 

 

 

247

 

Weighted average grant date fair value, per share

 

$

57.19

 

 

$

38.99

 

 

$

37.50

 

Pre-tax stock-based compensation

 

$

10,993

 

 

$

11,985

 

 

$

9,258

 

Summary of Activity for Service-Based Restricted Common Shares

The following table summarizes the activity for service-based restricted common shares for the fiscal years ended May 31:

 

 

 

2022

 

 

2021

 

 

2020

 

(in thousands, except per share amounts)

 

Restricted
Common
Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Restricted
Common
Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Restricted
Common
Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

Outstanding, beginning of year

 

 

777

 

 

$

40.36

 

 

 

643

 

 

$

41.79

 

 

 

811

 

 

$

43.25

 

Granted

 

 

192

 

 

 

57.19

 

 

 

307

 

 

 

38.99

 

 

 

247

 

 

 

37.50

 

Vested

 

 

(295

)

 

 

42.90

 

 

 

(146

)

 

 

43.41

 

 

 

(395

)

 

 

42.00

 

Forfeited

 

 

(24

)

 

 

42.36

 

 

 

(27

)

 

42.15

 

 

 

(20

)

 

 

44.10

 

Outstanding, end of year

 

 

650

 

 

$

44.12

 

 

 

777

 

 

$

40.36

 

 

 

643

 

 

$

41.79

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   outstanding restricted common shares (in years)

 

 

1.25

 

 

 

 

 

 

1.33

 

 

 

 

 

 

1.55

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregate intrinsic value of outstanding restricted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   common shares

 

$

30,283

 

 

 

 

 

$

51,541

 

 

 

 

 

$

19,230

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregate intrinsic value of restricted common

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   shares vested during the year

 

$

16,534

 

 

 

 

 

$

5,873

 

 

 

 

 

$

15,322

 

 

 

 

Schedule of Assumptions Used to Determine Grant Date Fair Value of Market Based Restricted Common Shares The following assumptions were used to determine the grant-date fair value and the derived service period for these market-based restricted common shares:

 

Dividend yield

 

 

1.60

%

Expected volatility

 

 

44.00

%

Risk-free interest rate

 

 

1.70

%

The following assumptions were used to determine the grant-date fair value and the derived service period for these restricted common shares:

 

Dividend yield

 

 

2.16

%

Expected volatility

 

 

33.60

%

Risk-free interest rate

 

 

2.96

%

The following assumptions were used to determine the grant-date fair value and the derived service period for these restricted common shares:

 

Dividend yield

 

 

2.69

%

Expected volatility

 

 

34.90

%

Risk-free interest rate

 

 

1.60

%

 

On June 25, 2020, we granted an aggregate of 45,000 market-based restricted common shares to three key employees under one of the Plans. Vesting of these restricted common share awards is contingent upon the average closing price of the common shares reaching $65.00 during any 90 consecutive day period during the five-year period following the date of grant and completion of a three-year service vesting period. The grant date fair value of these restricted common shares, as determined by a Monte Carlo simulation model, was $20.87 per share. The following assumptions were used to determine the grant-date fair value and the derived service period for these restricted common shares:

 

Dividend yield

 

 

2.71

%

Expected volatility

 

 

41.50

%

Risk-free interest rate

 

 

0.32

%

Performance Shares Granted

The table below sets forth the performance shares we granted (at target levels) during fiscal 2022, fiscal 2021 and fiscal 2020:

 

(in thousands, except per share amounts)

 

2022

 

 

2021

 

 

2020

 

Granted

 

 

36

 

 

 

64

 

 

 

55

 

Weighted average grant date fair value, per share

 

$

60.19

 

 

$

36.93

 

 

$

38.91

 

Pre-tax stock-based compensation

 

$

2,191

 

 

$

2,362

 

 

$

2,159

 

Summary of Performance Award Activity

The following table summarizes our performance award activity for the fiscal years ended May 31:

 

 

 

2022

 

 

2021

 

 

2020

 

(in thousands, except per share amounts)

 

Performance
Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Performance
Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

 

Performance
Shares

 

 

Weighted
Average
Grant
Date Fair
Value

 

Outstanding, beginning of year

 

 

177

 

 

$

39.23

 

 

 

158

 

 

$

42.45

 

 

 

149

 

 

$

45.00

 

Granted

 

 

67

 

 

 

52.22

 

 

 

65

 

 

 

36.93

 

 

 

67

 

 

 

38.91

 

Vested

 

 

(65

)

 

 

42.82

 

 

 

(3

)

 

 

47.76

 

 

 

(24

)

 

 

44.91

 

Forfeited

 

 

(19

)

 

 

41.80

 

 

 

(43

)

 

 

46.86

 

 

 

(34

)

 

 

44.91

 

Outstanding, end of year

 

 

160

 

 

$

42.93

 

 

 

177

 

 

$

39.23

 

 

 

158

 

 

$

42.45

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life of

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   outstanding performance shares (in years)

 

 

0.90

 

 

 

 

 

 

1.17

 

 

 

 

 

 

1.23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregate intrinsic value of outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   performance shares

 

$

7,445

 

 

 

 

 

$

11,730

 

 

 

 

 

$

4,721

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aggregate intrinsic value of performance

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   shares vested during the year

 

$

3,994

 

 

 

 

 

$

100

 

 

 

 

 

$

968